Login to Your Account



Inspiration Launches Second Trial of OBI-1 in Hemophilia A

By Marie Powers
Staff Writer

Monday, November 28, 2011
Inspiration Biopharmaceuticals Inc. initiated patient enrollment in the second of two pivotal studies of the company's OBI-1 Accur8 Phase III hemophilia program.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription